STAAR Surgical (STAA) Competitors

Haemonetics (NYSE:HAE) and STAAR Surgical (NASDAQ:STAA) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, community ranking, earnings, institutional ownership, analyst recommendations, risk and profitability.

Is HAE or STAA more profitable?

Haemonetics has a net margin of 9.10% compared to STAAR Surgical's net margin of 6.38%. Haemonetics' return on equity of 22.67% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haemonetics	9.10%	22.67%	8.83%
STAAR Surgical	6.38%	6.77%	5.39%

Do analysts recommend HAE or STAA?

Haemonetics currently has a consensus price target of $108.78, suggesting a potential upside of 33.09%. STAAR Surgical has a consensus price target of $42.83, suggesting a potential upside of 68.70%. Given STAAR Surgical's higher possible upside, analysts clearly believe STAAR Surgical is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haemonetics	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.89
STAAR Surgical	1 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.33

Does the media favor HAE or STAA?

In the previous week, Haemonetics had 5 more articles in the media than STAAR Surgical. MarketBeat recorded 10 mentions for Haemonetics and 5 mentions for STAAR Surgical. Haemonetics' average media sentiment score of 1.07 beat STAAR Surgical's score of -0.01 indicating that Haemonetics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haemonetics	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
STAAR Surgical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Do institutionals and insiders believe in HAE or STAA?

99.7% of Haemonetics shares are owned by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are owned by institutional investors. 1.8% of Haemonetics shares are owned by company insiders. Comparatively, 1.0% of STAAR Surgical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in HAE or STAA?

Haemonetics received 107 more outperform votes than STAAR Surgical when rated by MarketBeat users. Likewise, 61.43% of users gave Haemonetics an outperform vote while only 55.38% of users gave STAAR Surgical an outperform vote.

Company	Underperform	Outperform
Haemonetics	Outperform Votes 395 61.43%	Underperform Votes 248 38.57%
STAAR Surgical	Outperform Votes 288 55.38%	Underperform Votes 232 44.62%

Which has more volatility & risk, HAE or STAA?

Haemonetics has a beta of 0.38, indicating that its share price is 62% less volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500.

Which has stronger earnings and valuation, HAE or STAA?

Haemonetics has higher revenue and earnings than STAAR Surgical. Haemonetics is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haemonetics	$1.36B	3.02	$117.56M	$2.41	33.91
STAAR Surgical	$322.42M	3.88	$21.35M	$0.44	57.70

Summary

Haemonetics beats STAAR Surgical on 15 of the 19 factors compared between the two stocks.